TORONTO, Nov. 18 /CNW/ - Patheon (TSX: PTI - News) a global provider of drug development and manufacturing services to the international pharmaceutical industry has relaunched its alliance with Depomed(TM) (NYSE:DEPO - News), a specialty pharmaceutical company focused on enhancing pharmaceutical products, as part of Patheon's commitment on providing the best development and commercialization service offerings.
